跳至主要内容
临床试验/KCT0007244
KCT0007244尚未招募未知

Comparison of the hemodynamic stability of remimazolam versus dexmedetomidine during ultrasound-guided radiofrequency ablation of hepatic tumor under monitored anesthesia care

Asan Medical Center0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 79?(Year)(—)
性别
All

入选标准

  • Patients undergoing ultrasound-guided percutaneous liver radiofrequency ablation under monitored anesthesia care

排除标准

  • 1. Patients with a history of drug allergy to dexmedetomidine, benzodiazepine, or opioid analgesics
  • 2. Patients with contraindications to dexmedetomidine, remimazolam, or remifentanil
  • 3. Patients with body classification 3 or higher by the American Society of Anesthesiologists Physical Status
  • 4. Patients with a body mass index of 35 or higher
  • 5. Child-Pugh class C cirrhosis
  • 6. Patients undergoing dialysis for end-stage renal disease
  • 7. Patients scheduled for RFA under general anesthesia
  • 8. Patients judged to be inappropriate by other researchers

研究者

相似试验

Comparison of the hemodynamic stability of... | 临床试验